Quality of life analysis after stereotactic radiofrequency ablation of liver tumors
Open Access
- 30 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-12
- https://doi.org/10.1038/s41598-020-69331-1
Abstract
The purpose of this study was to evaluate the health-related quality of life (HRQoL) after stereotactic radiofrequency ablation (SRFA) of liver tumors and identify variables associated with decreased HRQoL and to compare it to other treatments in case of concurrency. From 2011 to 2017 577 patients underwent SRFA for liver tumors in 892 ablation sessions. 303 (52.5%) patients completed a HRQoL questionnaire once after the ablation. HRQoL was assessed by the Short Form (SF)-12 health survey with mental and physical component scales and by a general questionnaire to assess disease and treatment-specific items as well as to compare tolerability of SRFA to transarterial chemoembolization (TACE), hepatic resection (HR) and chemotherapy (CTX). The median SF-12 PCS was 46.6 and MCS was 53.2. Patients experiencing pain or complications and patients refusing repeat SRFA showed significantly lower PCS (43.2 vs 48.6, p=0.0003; 32.8 vs 46.9, p=0.005 and 40.6 vs 46.9, p=0.009). 355 (97.8%) patients indicated willingness to undergo repeat SRFA with little to no fear in 292 (80.7%) patients. Among patients with multiple therapies, SRFA was rated by 40 (90.9%) as preferred re-treatment, HR by 1 (2.3%) and CTX by 3 (6.8%). In conclusion, we have shown that SRFA has good HRQoL-outcomes and reported low morbidity rates. Consequently the vast majority of study patients would accept a repeated SRFA if necessary (97.8%), without fear (80.7%). SRFA was preferred among patients who experienced concurrent treatments, such as HR or CTX.This publication has 33 references indexed in Scilit:
- Quality of life, risk assessment, and safety research in liver transplantationCurrent Opinion in Organ Transplantation, 2012
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatmentSurgical Oncology, 2012
- Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinomaWorld Journal of Gastroenterology, 2012
- Liver resection and local ablation of breast cancer liver metastases – A systematic reviewEuropean Journal of Surgical Oncology, 2011
- Quality of life after curative liver resection: A single center analysisWorld Journal of Gastroenterology, 2010
- Quality of life after liver resection for hepatobiliary malignanciesBritish Journal of Surgery, 2008
- Radiofrequency Ablation for Metachronous Liver Metastasis from Colorectal Cancer after Curative SurgeryAnnals of Surgical Oncology, 2007
- Outcome After Hepatectomy for Multiple (Four or More) Colorectal Metastases in the Era of Effective ChemotherapyAnnals of Surgical Oncology, 2006
- Quality of life in patients with hepatocellular carcinoma received surgical resectionJournal of Surgical Oncology, 2006